华仁药业 (300110)
Huaren Pharmaceutical Co.,Ltd.
K-Line Chart
No K-line data available
Company NameHuaren Pharmaceutical Co., Ltd.
Listing Date2010-08-25
Issue Price13.99RMB
Registered Capital118221.298210k RMB
Legal RepresentativeZhang Li
Registered AddressNo. 187 Zhuzhou Road, High-tech Industrial Park, Qingdao City, Shandong Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, design, production, and sales of non-PVC large-volume infusion products.
Company ProfileHuaren Pharmaceutical was founded in May 1998. It is a state-controlled pharmaceutical and health industry group integrating production, education, and research, focusing on non-PVC soft bag infusions, medical devices, and medical services. It is a designated infusion production enterprise for emergency reserves in Shandong Province.
In August 2010, the company successfully listed on the Shenzhen Stock Exchange, with the stock abbreviation "Huaren Pharmaceutical" and stock code "300110". In July 2019, the company underwent an equity change, and the Xi'an Qujiang New District Management Committee became the company's actual controller.
The company's main business covers four segments: basic infusions, therapeutic infusions, peritoneal dialysis solutions, and medical devices. At its inception, the company focused on high-end non-PVC soft bag infusions, introducing the world's most advanced core production equipment from Europe, ensuring consistently leading product quality. Over 21 years, the company now has a total of 69 infusion product varieties and 143 specifications. The peritoneal dialysis solution launched by the company is the first batch-marketed non-PVC packaged product in China, successfully selected for the National Health Commission's Peritoneal Dialysis Demonstration and Promotion Project and the "12th Five-Year Plan" National Science and Technology Support Program.
Stock Details
1. Key Indicators
- Total Shares(W): 118221.30
- Circulating A-Shares(W): 118084.76
- Earnings Per Share(RMB): 0.0462
- Net Assets Per Share(RMB): 1.1465
- Operating Revenue(W RMB): 97627.04
- Total Profit(W RMB): 6327.80
- Net Profit Attributable to Parent(W RMB): 5457.98
- Net Profit Growth Rate(%): -42.87
- Weighted Return on Equity(%): 4.1100
- Operating Cash Flow Per Share(RMB): 0.2170
- Undistributed Profit Per Share(RMB): -0.3768
- Capital Reserve Per Share(RMB): 0.4467
2. Main Business
The main business covers:
- Pharmaceuticals
- Medical Devices
- Medical Packaging Materials
- Health & Wellness
- Pharmaceutical Commercial Distribution
3. Company Basic Information
- Company Name: Huaren Pharmaceutical Co., Ltd.
- Listing Date: 2010-08-25
- Industry: Pharmaceutical Manufacturing
- Address: No. 187 Zhuzhou Road, High-tech Industrial Park, Qingdao City, Shandong Province
- Website: www.qdhuaren.com
- Company Profile: The company's predecessor was Qingdao Huaren Pharmaceutical Co., Ltd., established on May 20, 1998. On August 23, 2001, based on the audited net asset value of RMB 50,100,000.00 (parent company basis) as of June 30, 2001, as per the audit report issued by Shandong Huide Certified Public Accountants, Qingdao Huaren Pharmaceutical Co., Ltd. was converted into Qingdao Huaren Pharmaceutical Co., Ltd. (joint stock company) at a 1:1 ratio, resulting in 50.10 million shares. The shareholding proportions of all shareholders remained unchanged before and after the conversion, and all assets, liabilities, business, and personnel of the limited company were assumed by the newly formed joint stock company. On August 23, 2001, the company was registered and established with the Qingdao Administration for Industry and Commerce, with a registered capital of RMB 50.10 million.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Xi'an Qujiang Tianshou Health Investment Partnership (Limited Partnership) | General Legal Person | 23644.26 | 20.02 |
| 2 | Huaren Century Group Co., Ltd. | General Legal Person | 8154.30 | 6.91 |
| 3 | Yongyu Hengfeng Investment Management Co., Ltd. | General Legal Person | 5749.61 | 4.87 |
| 4 | Hongta Innovation Investment Co., Ltd. | General Legal Person | 5680.46 | 4.81 |
5. Concept Sectors
- Mask Protection
- Hepatitis Concept
- Margin Trading & Securities Lending
- Major Shareholder Reduction
- Planned Reduction
- Micro & Small Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information